NIP
MYOK

Nicholas Investment Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Nicholas Investment Partners’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-130,321
Closed -$17.8M – 195
2020
Q3 		$17.8M Buy
130,321
+101,286
+349% +$10.8M 1.92% 8
2020
Q2 		$2.81M Sell
29,035
-31,273
-52% -$2.61M 0.57% 67
2020
Q1 		$2.83M Sell
60,308
-2,326
-4% -$149K 0.55% 76
2019
Q4 		$4.57M Sell
62,634
-34,426
-35% -$2.09M 0.47% 65
2019
Q3 		$5.06M Sell
97,060
-821
-0.8% -$43.7K 0.43% 83
2019
Q2 		$4.91M Sell
97,881
-2,213
-2% -$108K 0.45% 76
2019
Q1 		$5.2M Buy
100,094
+21,681
+28% +$999K 0.46% 64
2018
Q4 		$3.83M Sell
78,413
-1,945
-2% -$107K 0.41% 86
2018
Q3 		$5.24M Buy
+80,358
New +$4.73M 0.42% 81

Nicholas Investment Partners's MYOK Position: Q4 2020 in Review

Nicholas Investment Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 130,321 shares — an estimated $17.8M sold.

Nicholas Investment Partners first reported a position in MYOK in Q3 2018 and held it in 9 quarters. The position peaked at $17.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Nicholas Investment Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Nicholas Investment Partners sold 130,321 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $17.8M.
  • Nicholas Investment Partners first reported a position in MyoKardia, Inc. Common Stock in Q3 2018 and held it in 9 quarters.
  • Nicholas Investment Partners's MyoKardia, Inc. Common Stock position peaked at $17.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Nicholas Investment Partners's 13F filing for Q4 2020, filed 11 Feb 2021.